
| Title Name | IGNOU MSTE 3 SOLVED ASSIGNMENT |
|---|---|
| Type | Soft Copy (E-Assignment) .pdf |
| University | IGNOU |
| Degree | PG DIPLOMA PROGRAMMES |
| Course Code | PGDAST |
| Course Name | Post Graduate Diploma in Applied Statistics |
| Subject Code | MSTE 3 |
| Subject Name | Biostatistics-I |
| Year | 2026 |
| Session | |
| Language | English Medium |
| Assignment Code | MSTE-03/Assignmentt-1//2026 |
| Product Description | Assignment of PGDAST (Post Graduate Diploma in Applied Statistics) 2026. Latest MSTE 03 2026 Solved Assignment Solutions |
| Last Date of IGNOU Assignment Submission | Last Date of Submission of IGNOU MSTE-03 (PGDAST) 2026 Assignment is for January 2026 Session: 30th September, 2026 (for December 2026 Term End Exam).Semester WiseJanuary 2026 Session: 30th March, 2026 (for June 2026 Term End Exam).July 2026 Session: 30th September, 2026 (for December 2026 Term End Exam). |
Ques 1.
State whether the following statements are True or False. Give reason in support of your answer:
(a) Equality of slopes is the basic requirement for the parallel-line assay.
(b) The quantal assay is applicable when the response is the percentage of subjects who responded to a treatment at different doses.
(c) A complete life table is more elaborate than an abridged life table.
(d) Primary prevention includes strategies designed to reduce the incidence of disease.
(e) In Phase II of a clinical trial, we determine a safe dosage range and identify potential side effects.
Ques 2.
In a quantal assay, the number of cured cases for five doses of a standard and four doses of a new test drug are recorded in the following table:
| d_i} | {n_i}$ | {r_i} | |
|---|---|---|---|
| Standard | 3 | 28 | 4 |
| 6 | 30 | 8 | |
| 9 | 24 | 12 | |
| 12 | 32 | 22 | |
| 15 | 27 | 21 | |
| Test | 2 | 31 | 3 |
| 4 | 25 | 9 | |
| 6 | 30 | 16 | |
| 8 | 25 | 16 |
Determine the median effective dose for the standard and test drugs using regression model.
Ques 3.
Write a short note on the Sampling Registration method of data collection for vital statistics.
Ques 4.
The number of births occurring in a country in 2015 classified according to age of mother, together with the female population in each group of the childbearing period, is given as follows:
| Age | Female Population (in '000) | Number of Births to the mother in the age group |
|---|---|---|
| 15 - 19 | 84.79 | 2,343 |
| 20 - 24 | 70.01 | 14,541 |
| 25 - 29 | 72.66 | 16,736 |
| 30 - 34 | 75.92 | 10,218 |
| 35 - 39 | 75.10 | 5,134 |
| 40 - 44 | 71.62 | 1,422 |
| 45 - 49 | 66.66 | 93 |
| Total | 516.66 | 50,487 |
The total population of the country in 2015 was 2285.8 thousand. Using the given information, determine the following:
(i) CBR,
(ii) GFR,
(iii) ASFR for the country in 1958.
Ques 5.
(a) In a hypothetical study, 10 patients with kidney disease were randomly assigned to receive two dialysis methods (A and B). 5 patients received Dialysis-A followed by Dialysis-B, and the remaining 5 received Dialysis-B followed by Dialysis-A. The kidney function scores of these patients are given as:
| Group-I (AB Sequence) | |||||
|---|---|---|---|---|---|
| Patient No. | 1 | 2 | 3 | 4 | 5 |
| Dialysis-A | 69 | 73 | 50 | 69 | 76 |
| Dialysis-B | 68 | 79 | 68 | 72 | 85 |
| Group-II (BA Sequence) | |||||
|---|---|---|---|---|---|
| Patient No. | 6 | 7 | 8 | 9 | 10 |
| Dialysis-B | 57 | 70 | 75 | 70 | 69 |
| Dialysis-A | 51 | 71 | 53 | 62 | 64 |
Test whether the mean score for dialysis-A is different from the mean score of dialysis-B, assuming no carry-over effect.
(b) Describe descriptive and analytic epidemiology.
Ques 6.
Explain any five types of biases in clinical trials.
Ques 7.
Differentiate between direct and indirect bioassays.
Ques 8.
Explain the steps taken for minimising bias in a research setup of a clinical trial.
Ques 9.
Define experimental and non-experimental studies.
Ques 10.
State whether the following statements are True or False. Give reason in support of your answer:
(a) Equality of slopes is the basic requirement for the parallel-line assay.
(b) The quantal assay is applicable when the response is the percentage of subjects who responded to a treatment at different doses.
(c) A complete life table is more elaborate than an abridged life table.
(d) Primary prevention includes strategies designed to reduce the incidence of disease.
(e) In Phase II of a clinical trial, we determine a safe dosage range and identify potential side effects.
Ques 11.
In a quantal assay, the number of cured cases for five doses of a standard and four doses of a new test drug are recorded in the following table:
| d_i} | {n_i}$ | {r_i} | |
|---|---|---|---|
| Standard | 3 | 28 | 4 |
| 6 | 30 | 8 | |
| 9 | 24 | 12 | |
| 12 | 32 | 22 | |
| 15 | 27 | 21 | |
| Test | 2 | 31 | 3 |
| 4 | 25 | 9 | |
| 6 | 30 | 16 | |
| 8 | 25 | 16 |
Determine the median effective dose for the standard and test drugs using regression model.
Ques 12.
Write a short note on the Sampling Registration method of data collection for vital statistics.
Ques 13.
The number of births occurring in a country in 2015 classified according to age of mother, together with the female population in each group of the childbearing period, is given as follows:
| Age | Female Population (in '000) | Number of Births to the mother in the age group |
|---|---|---|
| 15 - 19 | 84.79 | 2,343 |
| 20 - 24 | 70.01 | 14,541 |
| 25 - 29 | 72.66 | 16,736 |
| 30 - 34 | 75.92 | 10,218 |
| 35 - 39 | 75.10 | 5,134 |
| 40 - 44 | 71.62 | 1,422 |
| 45 - 49 | 66.66 | 93 |
| Total | 516.66 | 50,487 |
The total population of the country in 2015 was 2285.8 thousand. Using the given information, determine the following:
(i) CBR,
(ii) GFR,
(iii) ASFR for the country in 1958.
Ques 14.
(a) In a hypothetical study, 10 patients with kidney disease were randomly assigned to receive two dialysis methods (A and B). 5 patients received Dialysis-A followed by Dialysis-B, and the remaining 5 received Dialysis-B followed by Dialysis-A. The kidney function scores of these patients are given as:
| Group-I (AB Sequence) | |||||
|---|---|---|---|---|---|
| Patient No. | 1 | 2 | 3 | 4 | 5 |
| Dialysis-A | 69 | 73 | 50 | 69 | 76 |
| Dialysis-B | 68 | 79 | 68 | 72 | 85 |
| Group-II (BA Sequence) | |||||
|---|---|---|---|---|---|
| Patient No. | 6 | 7 | 8 | 9 | 10 |
| Dialysis-B | 57 | 70 | 75 | 70 | 69 |
| Dialysis-A | 51 | 71 | 53 | 62 | 64 |
Test whether the mean score for dialysis-A is different from the mean score of dialysis-B, assuming no carry-over effect.
(b) Describe descriptive and analytic epidemiology.
Ques 15.
Explain any five types of biases in clinical trials.
Ques 16.
Differentiate between direct and indirect bioassays.
Ques 17.
Explain the steps taken for minimising bias in a research setup of a clinical trial.
Ques 18.
Define experimental and non-experimental studies.
Looking for IGNOU MSTE 3 Solved Assignment 2026. You are on the Right Website. We provide Help book of Solved Assignment of PGDAST MSTE 3 - Biostatistics-Iof year 2026 of very low price.
If you want this Help Book of IGNOU MSTE 3 2026 Simply Call Us @ 9199852182 / 9852900088 or you can whatsApp Us @ 9199852182
IGNOU PGDAST Assignments Jan - July 2025 - IGNOU University has uploaded its current session Assignment of the PGDAST Programme for the session year 2026. Students of the PGDAST Programme can now download Assignment questions from this page. Candidates have to compulsory download those assignments to get a permit of attending the Term End Exam of the IGNOU PGDAST Programme.
Download a PDF soft copy of IGNOU MSTE 3 Biostatistics-I PGDAST Latest Solved Assignment for Session January 2025 - December 2025 in English Language.
If you are searching out Ignou PGDAST MSTE 3 solved assignment? So this platform is the high-quality platform for Ignou PGDAST MSTE 3 solved assignment. Solved Assignment Soft Copy & Hard Copy. We will try to solve all the problems related to your Assignment. All the questions were answered as per the guidelines. The goal of IGNOU Solution is democratizing higher education by taking education to the doorsteps of the learners and providing access to high quality material. Get the solved assignment for MSTE 3 Biostatistics-I course offered by IGNOU for the year 2026.Are you a student of high IGNOU looking for high quality and accurate IGNOU MSTE 3 Solved Assignment 2026 English Medium?
Students who are searching for IGNOU Post Graduate Diploma in Applied Statistics (PGDAST) Solved Assignments 2026 at low cost. We provide all Solved Assignments, Project reports for Masters & Bachelor students for IGNOU. Get better grades with our assignments! ensuring that our IGNOU Post Graduate Diploma in Applied Statistics Solved Assignment meet the highest standards of quality and accuracy.Here you will find some assignment solutions for IGNOU PGDAST Courses that you can download and look at. All assignments provided here have been solved.IGNOU MSTE 3 SOLVED ASSIGNMENT 2026. Title Name MSTE 3 English Solved Assignment 2026. Service Type Solved Assignment (Soft copy/PDF).
Are you an IGNOU student who wants to download IGNOU Solved Assignment 2024? IGNOU PG DIPLOMA PROGRAMMES Solved Assignment 2023-24 Session. IGNOU Solved Assignment and In this post, we will provide you with all solved assignments.
If you’ve arrived at this page, you’re looking for a free PDF download of the IGNOU PGDAST Solved Assignment 2026. PGDAST is for Post Graduate Diploma in Applied Statistics.
IGNOU solved assignments are a set of questions or tasks that students must complete and submit to their respective study centers. The solved assignments are provided by IGNOU Academy and must be completed by the students themselves.
| Course Name | Post Graduate Diploma in Applied Statistics |
| Course Code | PGDAST |
| Programm | PG DIPLOMA PROGRAMMES Courses |
| Language | English |
| IGNOU MSTE 3 Solved Assignment | ignou assignment 2026, 2026 MSTE 3 | ||
| IGNOU MSTE 3 Assignment | ignou solved assignment MSTE 3 | ||
| MSTE 3 Assignment 2026 | solved assignment MSTE 3 | ||
| MSTE 3 Assignment 2026 | assignment of ignou MSTE 3 | ||
| Download IGNOU MSTE 3 Solved Assignment 2026 |
| ||
| Ignou result MSTE 3 | Ignou Assignment Solution MSTE 3 |
Click to Contact Us
Call - 9199852182 Call - 9852900088 myabhasolutions@gmail.com WhatsApp - 9852900088